Altis Labs
Toronto, Canada
◆ Total Raised
$25M
◆ Stage
series-a
◆ Location
Toronto, Canada
◆ Founded
2020
◆ Team size
11-50
◆ Links
◆ About Altis Labs
Toronto-based healthtech startup providing AI-powered prognosis platform for clinical oncology trials that detects treatment effects from radiology scans.
◆ What sets it apart
Uses AI trained on real-world survival outcomes to turn standard CT/radiology scans into prognostic trial endpoints that can reveal treatment benefit earlier than conventional imaging measures.
◆ Sectors
◆ Business
ModelSaaS
CustomerBiopharmaceutical companies and oncology clinical trial sponsors
◆ Notable
- Raised US$25 million Series A co-led by OrbiMed and Qiming Venture Partners USA
- Presented AI imaging endpoint results showing early treatment-effect detection at WCLC 2026
- Flagship IPRO model predicts survival directly from routinely acquired radiology scans
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Altis Labs do?
Toronto-based healthtech startup providing AI-powered prognosis platform for clinical oncology trials that detects treatment effects from radiology scans.
Where is Altis Labs based?
Altis Labs is based in Toronto, Canada, founded in 2020.
How much has Altis Labs raised?
Altis Labs has raised $25M in tracked funding and is currently at the series-a stage.
Who has invested in Altis Labs?
Investors in Altis Labs include OrbiMed, Qiming Venture Partners USA, Innovation Endeavors, Benchstrength, Fusion Fund and Lumira Ventures (Cancer Breakthrough Fund).